176 related articles for article (PubMed ID: 3624436)
21. A modified ELISA for the detection of toxic shock syndrome toxin (TSST-1) in staphylococcal isolates.
Fey H; Pfister H; Boerlin P
Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Jan; 267(3):363-6. PubMed ID: 3376616
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.
Parsonnet J; Hansmann MA; Delaney ML; Modern PA; Dubois AM; Wieland-Alter W; Wissemann KW; Wild JE; Jones MB; Seymour JL; Onderdonk AB
J Clin Microbiol; 2005 Sep; 43(9):4628-34. PubMed ID: 16145118
[TBL] [Abstract][Full Text] [Related]
23. Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome. Evidence for additional toxins.
Garbe PL; Arko RJ; Reingold AL; Graves LM; Hayes PS; Hightower AW; Chandler FW; Broome CV
JAMA; 1985 May; 253(17):2538-42. PubMed ID: 3981783
[TBL] [Abstract][Full Text] [Related]
24. Staphylococci associated with toxic shock syndrome in the United Kingdom.
de Saxe MJ; Wieneke AA; de Azevedo J; Arbuthnott JP
Ann Intern Med; 1982 Jun; 96(6 Pt 2):991-6. PubMed ID: 6212009
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of coagulase-negative staphylococci for ability to produce toxic shock syndrome toxin 1.
Kreiswirth BN; Schlievert PM; Novick RP
J Clin Microbiol; 1987 Oct; 25(10):2028-9. PubMed ID: 3117846
[TBL] [Abstract][Full Text] [Related]
26. Expression of type 8 capsular polysaccharide and production of toxic shock syndrome toxin 1 are associated among vaginal isolates of Staphylococcus aureus.
Lee JC; Liu MJ; Parsonnet J; Arbeit RD
J Clin Microbiol; 1990 Dec; 28(12):2612-5. PubMed ID: 2279990
[TBL] [Abstract][Full Text] [Related]
27. Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection.
Sharma H; Turner CE; Siggins MK; El-Bahrawy M; Pichon B; Kearns A; Sriskandan S
mSphere; 2019 Oct; 4(5):. PubMed ID: 31597722
[TBL] [Abstract][Full Text] [Related]
28. [Cases of menstrual toxic shock syndrome in the Czech Republic in 1997-2011].
Petrás P; Machová I; Rysková L; Prásil P
Epidemiol Mikrobiol Imunol; 2011 Nov; 60(4):161-6. PubMed ID: 22324245
[TBL] [Abstract][Full Text] [Related]
29. Persistence survey of toxic shock syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women.
Parsonnet J; Hansmann MA; Seymour JL; Delaney ML; Dubois AM; Modern PA; Jones MB; Wild JE; Onderdonk AB
BMC Infect Dis; 2010 Aug; 10():249. PubMed ID: 20731864
[TBL] [Abstract][Full Text] [Related]
30. Toxic shock syndrome in Britain--epidemiology and microbiology.
de Saxe MJ; Hawtin P; Wieneke AA
Postgrad Med J; 1985; 61 Suppl 1():5-21. PubMed ID: 4059160
[TBL] [Abstract][Full Text] [Related]
31. Characterization of toxin production of coagulase-negative staphylococci isolated from food and starter cultures.
Zell C; Resch M; Rosenstein R; Albrecht T; Hertel C; Götz F
Int J Food Microbiol; 2008 Oct; 127(3):246-51. PubMed ID: 18752861
[TBL] [Abstract][Full Text] [Related]
32. An association of membrane-damaging toxins from coagulase-negative staphylococci and chronic orofacial muscle pain.
Butt HL; Dunstan RH; McGregor NR; Roberts TK; Zerbes M; Klineberg IJ
J Med Microbiol; 1998 Jul; 47(7):577-84. PubMed ID: 9839561
[TBL] [Abstract][Full Text] [Related]
33. Effect of trace metals on the synthesis of toxic shock syndrome toxin 1.
Reeves MW
Rev Infect Dis; 1989; 11 Suppl 1():S145-49; discussion S149-50. PubMed ID: 2928630
[TBL] [Abstract][Full Text] [Related]
34. Co-production of staphylococcal enterotoxin A with toxic shock syndrome toxin-1 (TSST-1) enhances TSST-1 mediated mortality in a D-galactosamine sensitized mouse model of lethal shock.
De Boer ML; Kum WW; Pang LT; Chow AW
Microb Pathog; 1999 Aug; 27(2):61-70. PubMed ID: 10458917
[TBL] [Abstract][Full Text] [Related]
35. Toxin involvement in toxic shock syndrome.
Crass BA; Bergdoll MS
J Infect Dis; 1986 May; 153(5):918-26. PubMed ID: 3701106
[TBL] [Abstract][Full Text] [Related]
36. Investigation by syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus.
Lee AC; Crass BA; Bergdoll MS
J Clin Microbiol; 1987 Jan; 25(1):87-90. PubMed ID: 3793877
[TBL] [Abstract][Full Text] [Related]
37. Enterotoxin and toxic shock syndrome toxin-1 production of methicillin resistant and methicillin sensitive Staphylococcus aureus strains.
Schmitz FJ; MacKenzie CR; Geisel R; Wagner S; Idel H; Verhoef J; Hadding U; Heinz HP
Eur J Epidemiol; 1997 Sep; 13(6):699-708. PubMed ID: 9324218
[TBL] [Abstract][Full Text] [Related]
38. Spontaneous occurrence of Staphylococcus aureus mutants with different pigmentation and ability to produce toxic shock syndrome toxin 1.
Lee AC; Bergdoll MS
J Clin Microbiol; 1985 Aug; 22(2):308-9. PubMed ID: 4031043
[TBL] [Abstract][Full Text] [Related]
39. The toxic shock syndrome revisited.
Kass EH
Postgrad Med J; 1985; 61 Suppl 1():45-8. PubMed ID: 4059159
[TBL] [Abstract][Full Text] [Related]
40. Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome.
De Boer ML; Kum WW; Chow AW
Can J Microbiol; 1999 Mar; 45(3):250-6. PubMed ID: 10408098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
